News & Media / Newsroom
The agreement covers the countries of the European Union, the European Economic Area, the United Kingdom, Ukraine, Russia and the CIS.
Bentracimab is a human monoclonal antibody fragment to counteract the antiplatelet effects of ticagrelor.
After the recent acquisition of Lumeblue®, Alfasigma's pipeline is enriched with a biotechnological drug.
Alfasigma Polska is the General Sponsor of Polish Fencing Team “Victor”.
Alfasigma logo will be featured on sportswear, advertising bands and rollups
About Carnitine is the leading online global destination for healthcare professionals worldwide, offering the latest medical insights, expert perspectives and relevant professional education about the L-Carnitine molecule.
Alfasigma Mexico has been selected among more than 700 companies as one of the best 100 to work for in 2021.
The selection was determined by a survey sent to different employees in the Country by a moderating company.
The nomination of the Alfathon finalists took place during the first appointment with the INNOVATION TALKS, the Clubhouse room dedicated to technological innovation and health.
The United Nations marks April 21st as the World Creativity and Innovation Day. For that reason, Alfasigma launches INNOVATION TALKS, a Clubhouse room focused on innovation technologies and health.
Corporate Communication & Institutional Relations
Staff
[email protected] +39.051.6489.511Press Office
[email protected]You’re entering Alfasigma global website
I agree